ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,684 | -76.6% | 232,806 | -9.6% | 0.00% | – |
| Q2 2023 | $131,345 | +33.4% | 257,540 | +64.8% | 0.00% | – |
| Q1 2023 | $98,470 | -44.0% | 156,301 | -42.3% | 0.00% | – |
| Q4 2022 | $175,693 | -76.9% | 270,671 | -38.8% | 0.00% | -100.0% |
| Q3 2022 | $761,000 | +107.4% | 442,232 | +49.3% | 0.00% | 0.0% |
| Q2 2022 | $367,000 | +112.1% | 296,193 | +11.7% | 0.00% | – |
| Q1 2022 | $173,000 | -19.2% | 265,215 | +35.3% | 0.00% | – |
| Q4 2021 | $214,000 | -10.5% | 196,013 | +49.1% | 0.00% | – |
| Q3 2021 | $239,000 | -42.4% | 131,430 | -16.4% | 0.00% | -100.0% |
| Q2 2021 | $415,000 | +131.8% | 157,215 | +215.5% | 0.00% | – |
| Q1 2021 | $179,000 | -57.5% | 49,838 | -70.1% | 0.00% | -100.0% |
| Q4 2020 | $421,000 | +329.6% | 166,865 | +330.6% | 0.00% | – |
| Q3 2020 | $98,000 | -8.4% | 38,751 | +19.4% | 0.00% | – |
| Q2 2020 | $107,000 | +16.3% | 32,468 | -13.9% | 0.00% | -100.0% |
| Q1 2020 | $92,000 | -93.5% | 37,731 | -87.4% | 0.00% | -90.0% |
| Q4 2019 | $1,411,000 | -8.6% | 298,900 | -17.1% | 0.01% | -16.7% |
| Q3 2019 | $1,543,000 | -10.6% | 360,506 | +21.8% | 0.01% | -25.0% |
| Q2 2019 | $1,726,000 | +147.3% | 295,972 | +63.3% | 0.02% | +100.0% |
| Q1 2019 | $698,000 | +1.9% | 181,195 | -50.6% | 0.01% | +33.3% |
| Q4 2018 | $685,000 | -37.5% | 366,514 | +7.0% | 0.01% | -33.3% |
| Q3 2018 | $1,096,000 | +0.9% | 342,621 | -4.7% | 0.01% | 0.0% |
| Q2 2018 | $1,086,000 | +49.0% | 359,637 | +93.5% | 0.01% | +28.6% |
| Q1 2018 | $729,000 | -31.0% | 185,905 | -27.2% | 0.01% | 0.0% |
| Q4 2017 | $1,057,000 | -47.7% | 255,243 | -22.4% | 0.01% | -61.1% |
| Q3 2017 | $2,020,000 | +73.8% | 328,935 | +76.0% | 0.02% | +50.0% |
| Q2 2017 | $1,162,000 | +209.9% | 186,842 | +215.5% | 0.01% | +200.0% |
| Q1 2017 | $375,000 | -81.9% | 59,221 | -84.7% | 0.00% | -80.0% |
| Q4 2016 | $2,068,000 | -1.0% | 386,546 | +4.3% | 0.02% | -13.0% |
| Q3 2016 | $2,088,000 | -23.9% | 370,781 | -25.8% | 0.02% | -28.1% |
| Q2 2016 | $2,744,000 | +25.9% | 499,776 | +70.1% | 0.03% | +3.2% |
| Q1 2016 | $2,180,000 | -27.1% | 293,800 | -18.4% | 0.03% | -11.4% |
| Q4 2015 | $2,992,000 | +55.1% | 360,043 | +68.2% | 0.04% | +29.6% |
| Q3 2015 | $1,929,000 | -61.1% | 214,054 | -48.3% | 0.03% | -60.9% |
| Q2 2015 | $4,965,000 | +208.8% | 413,731 | +30.4% | 0.07% | +187.5% |
| Q4 2014 | $1,608,000 | +40.1% | 317,178 | -27.1% | 0.02% | +33.3% |
| Q3 2014 | $1,148,000 | -53.9% | 434,874 | -29.6% | 0.02% | -52.6% |
| Q2 2014 | $2,490,000 | +37.7% | 617,836 | +56.5% | 0.04% | +26.7% |
| Q1 2014 | $1,808,000 | +6.5% | 394,863 | +1.0% | 0.03% | +15.4% |
| Q4 2013 | $1,697,000 | +152.5% | 390,999 | +130.0% | 0.03% | +100.0% |
| Q3 2013 | $672,000 | +34.7% | 169,999 | -28.5% | 0.01% | +8.3% |
| Q2 2013 | $499,000 | – | 237,667 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |